aod9604 clinical trials fat loss results AOD-9604 vs MOTS-c vs Tesamorelin vs Semaglutide vs Tirzepatide aod9604 phase 2 trial results

NNMT inhibition and metabolic regulation

Besides those listed, RFK Jr

Oral or intraperitoneal administration of the product significantly reduces NNMT activity in solid tumor tissues, boosts intracellular NAD+ levels, inhibits rapid tumor cell proliferation, and cuts down tumor volume and weight without obvious damage to surrounding normal organs, indicating reliable high safety and precise targeting features

it stimulates lipolysis without affecting glucose metabolism, which makes it useful when you need to study fat mobilization independent of insulin pathways, but irrelevant for insulin resistance research

You can also contact us through our website.